HRMY - Harmony Biosciences acquires Epygenix gaining rare epilepsy pipeline
2024-04-30 08:53:48 ET
More on Harmony Biosciences
- Harmony Biosciences Holdings, Inc. (HRMY) Q4 2023 Earnings Call Transcript
- Harmony Biosciences Non-GAAP EPS of $0.88 beats by $0.10, revenue of $154.6M misses by $0.19M
- Harmony Biosciences Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Harmony Biosciences
- Historical earnings data for Harmony Biosciences